NPIL withdraws Parkinsonís drug

by Medindia Content Team on  October 20, 2001 at 11:43 AM Drug News
RSS Email Print This Page Comment
NPIL withdraws Parkinsonís drug
It has been reportedly said that Nicholas Piramal India Ltd which imports the raw material and manufactures Madopar, Parkinson's drug, locally has ceased its production in both vial and tablet form following price control.

The company had approached the National Pharmaceutical Pricing Authority (NPPA) to reconsider its price revision. However, according to NPPA sources the cased was already ''pending review'' with the Ministry of Chemicals and Fertilisers.

According to NPPA sources the 10 tablet strips came under the price control which the company launched after the price control on vials. The existing MRP of a 10 tablet strip of 250 mg was Rs 56, whereas the company was seeking an MRP of Rs 97.84 to make it viable for the company.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive